Metoprolol Succinate Tablet, Extended Release
Product Images NDC 62207-133

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 62207-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metoprolol-100mg-30s (Metoprolol 100mg 30s)

Description: This text is a label for a medication container. It includes information about the tablets containing metoprolol succinate, their dosage, storage instructions, and manufacturer details. The tablets contain 95 mg of metoprolol succinate, equivalent to 100 mg of metoprolol tartrate. The usual dosage is mentioned, and there is a warning to keep the medication out of reach of children. Storage instructions indicate storing at temperatures between 15°C to 30°C. The tablets are to be kept at 25°C (77°F). The manufacturer is Granules India Limited, and the product is manufactured for Granules Pharmaceuticals Inc.*

FDA Label Image

Metoprolol-200mg-30s (Metoprolol 200mg 30s)

This is a description of Metoprolol Succinate Extended-Release Tablets, USP. Each tablet contains 190 mg of metoprolol succinate, USP equivalent to 200 mg of metoprolol tartrate, USP. The usual dosage can be found in the package insert. It is important to keep this medication out of the reach of children. The tablets should be stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication is manufactured by Granules India Limited in Hyderabad, India, and is intended for Granules Pharmaceuticals Inc. in Chantilly, VA, 20151.*

FDA Label Image

Metoprolol-25mg-30s (Metoprolol 25mg 30s)

This text contains information about metoprolol succinate extended-release tablets, USP, with each tablet containing 23.75 mg of metoprolol succinate, USP. The medication is equivalent to 25 mg of metoprolol tartrate, USP. The recommended storage conditions are at 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The manufacturer is Granules India Limited in Hyderabad, India. It is manufactured for Granules Pharmaceuticals Inc. in Chantilly, VA. The NDC number for this product is 62207-130-54. The expiration date is 06/2023.*

FDA Label Image

Metoprolol-50mg-30s (Metoprolol 50mg 30s)

The text provides information about a medication with the NDC code 62207-133-54. It contains metoprolol succinate and is equivalent to 50 mg of metoprolol tartrate. The usual dosage information can be found in the package insert. The medication is extended-release and a warning to keep it out of reach of children. It should be stored at room temperature, between 15°C to 30°C (59°F to 86°F). The tablets are manufactured by Granules India Limited and distributed by Granules Pharmaceuticals Inc. Further information can be found on the packaging insert "See USP Controlled."*

FDA Label Image

Metoprolol-figure (Metoprolol Figure Jpg)

FDA Label Image

Metoprolol-structure (Metoprolol Structure Jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.